United Therapeutics (UTHR) Ownership
UTHR$597.14+8.53 +1.45%
Market cap$25.43BEnterprise value$24.91BRevenue (TTM)$3.19BMarket positionTop 25%
Score
50
Neutral
Value
26
Quality
84
Growth
40
Ownership data loads after the page opens.
United Therapeutics (UTHR) Ownership
UTHR price $597.14 +8.53 +1.45%
- Ticker
- UTHR
- Price
- $597.14
- Change
- +8.53 +1.45%
- Market cap
- $25.43B
- P/E
- 20.37
- Forward P/E
- 24.34
- Dividend yield
- 0.00%
- Beta
- 0.56
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 50
- Value
- 26
- Quality
- 84
- Growth
- 40
Stocklytics score rationale: value 26, quality 84, growth 40.
AI Score 75. United Therapeutics Corporation has a strong market cap of $26.1 billion and a solid net profit margin of 38.6%, indicating effective cost management. However, its high price-to-earnings ratio of approximately 21.3 and a price-to-sales ratio of 8.2 suggest that the stock may be overvalued relative to its earnings and sales growth potential
Insights · Forecast · Financials · Learn